Literature DB >> 30136028

Gravity-Independent Upbeat Nystagmus in Syndrome of Anti-GAD Antibodies.

Daniel Feldman1, Jorge Otero-Millan2, Aasef G Shaikh3.   

Abstract

An autoimmune disorder of the central nervous system, stiff person syndrome, frequently presents with increased titers of 65KD anti-glutamic acid decarboxylase (anti-GAD) antibodies. The clinical phenomenology of this syndrome includes stiffness, ataxia, vertigo due to horizontal gaze-evoked and downbeat vertical nystagmus, and dysmetria of saccades and reaching movements. Here, we describe a novel phenomenology of syndrome of anti-GAD antibody, non-position-dependent upbeat nystagmus and superimposed horizontal gaze-evoked nystagmus. Lack of gravity dependence of primary position upbeat nystagmus, intense nystagmus on up-gaze, relatively stable gaze on downward orientation, and the exponentially decaying waveform suggests neural integrator dysfunction. The titer of anti-GAD in our patient (30 U/ml) was consistent with a variant called "low-titer anti-GAD syndrome". In addition of presenting as an unusual manifestation of a rare neurological syndrome, this case presents a neurochemical correlate of upbeat nystagmus in GABA-mediated control system involving horizontal and vertical neural integrators. Furthermore, the variant of "low-titer anti-GAD syndrome" suggests that GABAergic system may be affected at lower level or antibodies, and/or the epitopes of antibody in those with full-blown clinical syndrome, but low titers of anti-GAD may be different.

Entities:  

Keywords:  Anti-GAD; Anti-gliadin; Brainstem; Cerebellum; Stiff person syndrome

Mesh:

Substances:

Year:  2019        PMID: 30136028      PMCID: PMC6428628          DOI: 10.1007/s12311-018-0972-z

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  22 in total

1.  Eye movement abnormalities in stiff person syndrome.

Authors:  John R Economides; Jonathan C Horton
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

2.  Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.

Authors:  Ioannis Markakis; Eleni Alexiou; Michael Xifaras; Georgios Gekas; Antonios Rombos
Journal:  Clin Neurol Neurosurg       Date:  2008-04-22       Impact factor: 1.876

3.  Anti-GAD antibodies and periodic alternating nystagmus.

Authors:  Caroline Tilikete; Alain Vighetto; Paul Trouillas; Jérome Honnorat
Journal:  Arch Neurol       Date:  2005-08

4.  GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.

Authors:  P Fouka; H Alexopoulos; S Akrivou; O Trohatou; P K Politis; M C Dalakas
Journal:  J Neuroimmunol       Date:  2015-03-10       Impact factor: 3.478

5.  Potential role of anti-GAD antibodies in abnormal eye movements.

Authors:  Caroline Tilikete; Alain Vighetto; Paul Trouillas; Jérome Honnorat
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

6.  Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates.

Authors:  A M Wong; S Musallam; R D Tomlinson; P Shannon; J A Sharpe
Journal:  J Neurol Sci       Date:  2001-08-15       Impact factor: 3.181

7.  Gaze fixation deficits and their implication in ataxia-telangiectasia.

Authors:  A G Shaikh; S Marti; A A Tarnutzer; A Palla; T O Crawford; D Straumann; A M Taylor; D S Zee
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-04-08       Impact factor: 10.154

8.  A new familial disease of saccadic oscillations and limb tremor provides clues to mechanisms of common tremor disorders.

Authors:  Aasef G Shaikh; Kenichiro Miura; Lance M Optican; Stefano Ramat; R John Leigh; David S Zee
Journal:  Brain       Date:  2007-10-05       Impact factor: 13.501

9.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.

Authors:  M Solimena; F Folli; S Denis-Donini; G C Comi; G Pozza; P De Camilli; A M Vicari
Journal:  N Engl J Med       Date:  1988-04-21       Impact factor: 91.245

10.  Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations.

Authors:  Aasef G Shaikh; George Wilmot
Journal:  J Neurol Sci       Date:  2016-01-21       Impact factor: 3.181

View more
  1 in total

1.  Gaze-holding and anti-GAD antibody: prototypic heterogeneous motor dysfunction in immune disease.

Authors:  Wanchat Theeranaew; Fajun Wang; Fatema F Ghasia; George Wilmot; Aasef G Shaikh
Journal:  Cerebellum       Date:  2021-05-11       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.